Australia markets closed

Burning Rock Biotech Limited (BNR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.2100+0.0400 (+1.26%)
At close: 04:00PM EST
3.2777 +0.07 (+2.11%)
After hours: 04:48PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.1700
Open3.2300
Bid3.1000 x 800
Ask3.4500 x 900
Day's range3.0800 - 3.2500
52-week range1.7000 - 11.2700
Volume160,690
Avg. volume225,095
Market cap339.377M
Beta (5Y monthly)0.07
PE ratio (TTM)N/A
EPS (TTM)-1.2680
Earnings date20 Mar 2023 - 24 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.81
  • GlobeNewswire

    Burning Rock provides an update on 2022 revenue guidance

    GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it expects the Company’s full-year revenue growth for 2022 to be approximately 10% compared to that of 2021. This represents an upward revision compared with the Company’s previous guidance on the full-year revenue gr

  • Simply Wall St.

    Even after rising 28% this past week, Burning Rock Biotech (NASDAQ:BNR) shareholders are still down 63% over the past year

    It is doubtless a positive to see that the Burning Rock Biotech Limited ( NASDAQ:BNR ) share price has gained some 47...

  • GlobeNewswire

    Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

    IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its OverC™ Multi-Cancer Detection Blood Test (MCDBT) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA), which is the third of its kind globally. Under the FDA’s Breakthrough Devices Program, the Breakthrough Device Designation is gra